Novel ruthenium(III) dimers Na2[{trans-RuCl4(Me2SO-S)}2(μ-L)] and [{mer,cis-RuCl3(Me2SO-S)(Me2SO-O)} 2(μ-L)] (L = bridging heterocyclic N-donor ligand) closely related to the antimetastatic complex Na[trans-RuCl4(Me2SO-S)(Him)]

Journal of the Chemical Society - Dalton Transactions

Volumn , Issue 19, 1999, Pages 3361-3371

  Iengo, Elisabetta ^a   Mestroni, Giovanni ^a   Geremia, Silvano ^a   Calligaris, Mario ^a   Alessio, Enzo ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004796594     PISSN: 03009246     EISSN: None     Source Type: Journal    
DOI: 10.1039/a904264d     Document Type: Article

References (49)

1. (a) G. Mestroni, E. Alessio, G. Sava, S. Pacor and M. Coluccia, in Metal Complexes in Cancer Chemotherapy, ed. B. K. Keppler, VCH, Weinheim, 1993, pp. 157-185;
2. (b) G. Sava, S. Pacor, E. Alessio, G. Mestroni, R. Gagliardi, M. Cocchietto and M. Coluccia, Drugs of the Future, 1993, 18, 894;
3. (c) G. Mestroni, E. Alessio, G. Sava, S. Pacor, M. Coluccia and A. Boccarelli, Metal-Based Drugs, 1994, 1, 41.
4. G. Mestroni, E. Alessio and G. Sava, Int. Pat., WO 98/00431, 1998.
5. (a) G. Sava, I. Capozzi, K. Clerici, G. Gagliardi, E. Alessio and G. Mestroni, Clin. Exp. Metastasis, 1998, 16, 371;
6. (b) G. Sava, R. Gagliardi, M. Cocchietto, K. Clerici, I. Capozzi, M. Marella, E. Alessio, G. Mestroni and R. Milanino, Pathol. Oncol. Res., 1998, 4, 30;
7. (c) G. Sava, K. Clerici, I. Capozzi, M. Cocchietto, R. Gagliardi, E. Alessio, G. Mestroni and A. Perbellini, Anti-Cancer Drugs, 1999, 10, 129;
8. (d) A. Bergamo, R. Gagliardi, V. Scarcia, A. Furlani, E. Alessio, G. Mestroni and G. Sava, J. Pharmacol. Exp. Ther., 1999, 298, 559;
9. (e) G. Sava, E. Alessio, A. Bergamo and G. Mestroni, in Topics in Biological Inorganic Chemistry, eds. M. J. Clarke and P. J. Sadler, Springer-Verlag, Berlin and Heidelberg, 1999, vol. 1, pp. 143-169.
10. E. Alessio, G. Balducci, A. Lutman, G. Mestroni, M. Calligaris and W. M. Attia, Inorg. Chim. Acta, 1993, 203, 205.
11. B. K. Keppler, W. Rupp, U. M. Juhl, H. Enders, R. Niebl and W. Balzer, Inorg. Chem., 1987, 26, 4366.
12. B. K. Keppler, M. Henn, U. M. Juhl, M. R. Berger, R. Niebl and F. E. Wagner, in Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy, ed. M. J. Clarke, Springer, Heidelberg, 1989, vol. 14, pp. 41-70.
13. N. Farrell, Y. Qu, U. Bierbach, M. Valsecchi and E. Menta, in Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug, ed. B. Lippert, VHCA (Zurich) and Wiley-VCH (Weinheim), 1999, pp. 479-496;
14. N. Farrell, Comments Inorg. Chem., 1995, 16, 373;
15. Y. Qu, S. G. da Almeida and N. Farrell, Inorg. Chim. Acta, 1992, 201, 123.
16. E. Alessio, E. Iengo, G. Mestroni and G. Sava, It. Pat., MI99A000811, 1999.
17. M. D. Ward, Chem. Soc. Rev., 1995, 121;
18. B. J. Coe, T. J. Meyer and P. S. White, Inorg. Chem., 1995, 34, 593.
19. (a) C. Creutz and H. Taube, J. Am. Chem. Soc., 1969, 91, 3988;
20. (b) C. Creutz and H. Taube, J. Am. Chem. Soc., 1973, 95, 1086;
21. (c) S. A. Adeyemi, E. C. Johnson, F. J. Miller and T. J. Meyer, Inorg. Chem., 1973, 12, 2371;
22. (d) C. Creutz, Prog. Inorg. Chem., 1983, 30, 1;
23. (e) D. E. Richardson and H. Taube, Coord. Chem. Rev., 1984, 60, 107.
24. V. Balzani, A. Juris, M. Venturi, S. Campagna and S. Serroni, Chem. Rev., 1996, 96, 759.
25. F. Felix and A. Ludi, Inorg. Chem., 1978, 17, 1782.
26. F. M. Hornung, F. Baumann, W. Kaim, J. A. Olabe, L. D. Slep and J. Fiedler, Inorg. Chem., 1998, 37, 311.
27. Y. Chen and R. E. Shepherd, Inorg. Chem., 1998, 37, 1249.
28. J. P. Collman, J. T. McDevitt, C. R. Leinder, G. T. Yee, J. B. Torrance and W. A. Little, J. Am. Chem. Soc., 1987, 109, 4606.
29. C. K. Johnson, ORTEP II, Report ORNL-5138, Oak Ridge National Laboratory, Oak Ridge, TN, 1976.
30. M. Calligaris and O. Carugo, Coord. Chem. Rev., 1996, 153, 83.
31. S. Geremia, E. Alessio and F. Todone, Inorg. Chim. Acta, 1996, 253, 87.
32. E. Alessio, E. Iengo, S. Zorzet, A. Bergamo, M. Coluccia, A. Boccarelli and G. Sava, J. Inorg. Biochem., in press.
33. C. M. Duff and G. A. Heat, J. Chem. Soc., Dalton Trans., 1991, 2401.
34. P. Ford, De F. P. Rudd, R. Gaunder and H. Taube, J. Am. Chem. Soc, 1968, 90, 1187.
35. Comprehensive Coordination Chemistry, eds. G. Wilkinson, R. D. Gillard and J. A. McCleverty, Pergamon, Oxford, 1987, vol. 4, ch. 45, pp. 442-446.
36. O. M. Ni Dhubhghaill, W. R. Hagen, B. K. Keppler, K.-G. Lipponer and P. J. Sadler, J. Chem. Soc., Dalton Trans., 1994, 3305.
37. P. E. Dumas and E. E. Mercer, Inorg. Chem., 1972, 11, 531.
38. M. Henn, E. Alessio, G. Mestroni, M. Calligaris and W. M. Attia, Inorg. Chim. Acta, 1991,187, 39.
39. A. Yeh, N. Scott and H. Taube, Inorg. Chem., 1982, 21, 2542;
40. M. Sano and H. Taube, J. Am. Chem. Soc., 1991, 113, 2327;
41. A. Tomita and M. Sano, Inorg. Chem., 1994, 33, 5825;
42. M. Sano and H. Taube, Inorg. Chem., 1994, 33, 705.
43. E. Alessio, G. Balducci, M. Calligaris, G. Costa, W. M. Attia and G. Mestroni, Inorg. Chem., 1991, 30, 609.
44. E. Alessio, G. Mestroni, G. Nardin, W. M. Attia, M. Calligaris, G. Sava and S. Zorzet, Inorg. Chem., 1988, 27, 4099.
45. G. Sava, S. Pacor, M. Coluccia, M. Mariggio, M. Cocchietto, E. Alessio and G. Mestroni, Drug Invest., 1994, 8, 150.
46. L. Messori, F. Kratz and E. Alessio, Metal-Based Drugs, 1996, 3, 1.
47. L. Messori, P. Orioli, D. Vullo, E. Alessio and E. Iengo, unpublished work.
48. G. M. Sheldrick, Acta Crystallogr., Sect. A, 1990, 46, 467.
49. G. M. Sheldrick, SHELXL 93, Program for crystal structure refinement, Universität Göttingen, 1993.